Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

BACKGROUND: Vascular endothelial growth factor tyrosine-kinase inhibitors (VEGFR-TKIs) have emerged as an effective targeted therapy in the treatment of cancer patients, the overall incidence and risk of proteinuria associated these drugs is unclear. We performed a systematic review and meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ze-Feng, Wang, Tao, Liu, Li-Hua, Guo, Hui-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951202/
https://www.ncbi.nlm.nih.gov/pubmed/24621598
http://dx.doi.org/10.1371/journal.pone.0090135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951202/
https://www.ncbi.nlm.nih.gov/pubmed/24621598
http://dx.doi.org/10.1371/journal.pone.0090135

Ejemplares similares